Key Takeaways
- CRM shares have plunged over 30% during 2026, hitting a 52-week low at $174.57
- Board directors purchased CRM shares in March at approximately $194–$195 apiece
- The iShares Expanded Tech-Software Sector ETF has declined roughly 24% year-to-date
- The company exceeded Q4 projections with earnings per share of $3.81 versus the anticipated $3.05, while greenlighting a $25 billion stock repurchase initiative
- Several institutional stakeholders expanded their CRM holdings during Q4 2024
Salesforce has faced significant headwinds throughout 2026. The enterprise software giant has witnessed its market value decline by more than 30%, pressured by widespread selling across the software industry and mounting anxieties regarding artificial intelligence competition.
The stock’s descent accelerated toward the end of January, with concerns about AI disruption repeatedly weighing on investor sentiment. A notable trigger emerged when reports surfaced that Anthropic’s Claude artificial intelligence system possessed the capability to operate computers autonomously, raising questions about the long-term viability of traditional enterprise software solutions.
Yet amid the ongoing volatility, a pair of company board members made notable purchases of CRM shares during March.
Board member Laura Alber — concurrently serving as Williams-Sonoma’s chief executive — acquired 2,571 CRM shares priced at approximately $195 on March 19, for a total investment of $451,166. This marked her inaugural open-market transaction since her appointment to the board in November 2021.
Meanwhile, David Kirk, another board director and former Nvidia chief scientist, secured 2,570 CRM shares at $194.62 per share on March 18. This represented his first open-market acquisition of the calendar year. Kirk’s direct ownership now stands at 13,689 CRM shares with an estimated value around $2.5 million.
Impressive Financial Results and Repurchase Plan Fail to Halt Decline
Salesforce unveiled its Q4 financial performance on February 25, surpassing Wall Street expectations. Earnings per share reached $3.81, comfortably beating the consensus forecast of $3.05. Quarterly revenue totaled $11.20 billion, representing 12.1% growth compared to the prior year period and modestly exceeding analyst projections.
The board additionally greenlit a $25 billion share repurchase authorization on March 16 — a program substantial enough to retire approximately 14.1% of shares currently outstanding. The quarterly dividend received an increase to $0.44 from $0.42, translating to an annualized distribution of $1.76 per share.
Despite these positive developments, the stock has continued its downward trajectory. From March 19 — when Alber executed her purchase — shares have dropped an additional 7%.
Institutional Investors Continue Accumulating Positions
Among institutional participants, CMH Wealth Management expanded its CRM holdings by 37.3% throughout Q4, acquiring 10,102 additional shares to reach a total position of 37,208 shares, valued at $9.87 million. Multiple other investment funds similarly increased their allocations during the same timeframe.
Institutional investors and hedge funds collectively control 80.43% of outstanding CRM shares.
Wall Street analyst perspectives remain predominantly optimistic. The stock maintains an aggregate “Moderate Buy” rating accompanied by a consensus price objective of $280.21 — significantly above present trading levels. Individual analyst price targets span from $250 (TD Cowen) to $430 (Citizens JMP).
Agilysys (AGYS), another software company experiencing insider purchasing activity in mid-March, has appreciated 5.6% following director Melvin Keating’s acquisition of $27,289 worth of shares between March 16 and 17.



